The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer.

Ann Surg Oncol · 2017 · PMC5374176 · PMID 27873100

Europe PMC DOI

hedged sentence

0.0710

closest p · 1.4× alpha

0.0710

boldest claim

The sentences

approaching significanceP = 0.071so close (0.05 < p ≤ 0.1)

A good pathologic response to treatment was significantly associated with an mGPS of 0 ( P = 0.022), a normal NLR ( P = 0.052), and a PLR approaching significance ( P = 0.071) (Table 2 ).

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.